Identification and characterization of a novel nuclear structure containing members of the homologous recombination and DNA damage response pathways

Cancer Genet. 2018 Dec:228-229:98-109. doi: 10.1016/j.cancergen.2018.10.003. Epub 2018 Oct 18.

Abstract

The human RAD9A protein is required for successful execution of the G2/M DNA damage checkpoint. Along with RAD1 and HUS1, RAD9A exists in a heterotrimeric ring-shaped complex which is necessary for activation of the CHK1 checkpoint kinase. RAD9A is also required for proper localization of both TopBP1 and the Claspin adaptor protein during the DNA damage response. We have shown large, RAD9A-dense nuclear foci containing several members of the homologous recombination pathway as well as BRCA1 and the DNA damage marker γH2AX. This RAD9A-dense body is closely associated with the inactive X in HeLa cells but not in other cell types analyzed including a Klinefelter's syndrome-derived line containing multiple Xi. We have also shown these foci disappear after cell synchronization but are enriched after treatment with the homologous recombination inhibitor pentoxifylline. We conclude these foci are the result of an active process, suspended in perturbed cells, that involves interaction between the cell cycle checkpoint and homologous recombination machinery.

Keywords: 911 complex; DNA repair; Homologous recombination; RAD9A.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • BRCA1 Protein / genetics
  • Cell Cycle Proteins / genetics
  • Cell Nucleus / metabolism*
  • DNA Damage*
  • Fluorescent Antibody Technique
  • HeLa Cells
  • Histones / genetics
  • Homologous Recombination* / drug effects
  • Humans
  • MRE11 Homologue Protein / genetics
  • Pentoxifylline / administration & dosage

Substances

  • BRCA1 Protein
  • BRCA1 protein, human
  • Cell Cycle Proteins
  • H2AX protein, human
  • Histones
  • MRE11 protein, human
  • rad9 protein
  • MRE11 Homologue Protein
  • Pentoxifylline

Grants and funding